Fish Skin Disease Market Synopsis:
Fish Skin Disease Market Size Was Valued at USD 1.40 Billion in 2023, and is Projected to Reach USD 3.25 Billion by 2032, Growing at a CAGR of 9.80% From 2024-2032.
The Fish Skin Disease Market deals with the market sector that deals with the prevention, diagnosis and treatment of skin diseases in fish which may be as a result of influences by different factors such as the environment, pathogens and water quality. Some of them cause skin lesion, discoloration and skin infections in both wild fish and farmed fish. This market consists of various products like, drugs, vaccines, and creams that address these diseases. Further, knowledge and innovation involve enhancement of disease control measures that enhance health and productivity in fish farming.
There has been tremendous market growth in the fish skin disease market over the past few years, resulting from the rising cases in different skin ailments of fish species found within the aquaculture industry. Those skin diseases of fish due to pathogen factors like bacteria, fungi, viruses, or parasites will result in great infection, fish health and economic losses in aquaculture. Due to the growing world’s population and the people’s willingness to consume fish and seafood, more attention is being paid to the health and disease-free status of fish stock to guarantee therapeutic treatments and preventive measures for skin disease problems afflicting the fish.
The market is also affected by technologies in diagnostics whereby there are improvements in diagnosing diseases affecting the skin of fish with ease and tract them easily. In addition, new regulations by the governments to enhance the health of fishes and enhanced prevention of diseases affecting aquaculture farms are contributing to market growth. However, there are some threats in the market like the expensive treatments which caused a problem in large scale aquaculture farms and the possibility of developed drug resistance.
Fish Skin Disease Market Trend Analysis:
Rising Demand for Advanced Treatments in the Expanding Fish Farming Industry
-
Fish farming continues to expand due to increasing demand for fish and other seafood’s, the problem of skin diseases in fish has become rampant. This increase in skin diseases has clearly manifested in the countries with developing aquaculture businesses particularly the Asia-Pacific region in which high levels of fish production increase the vulnerability of diseases. These skin diseases are some of the biggest threats to the health and growth of farmed fish, hence being a major lead to loss making within the aquaculture business. For this reason, the application of high-level treatments and prevention to prevent these diseases and to maintain the health of the fish and to make less loss.
- Many people have become more concern about fish health and the cost of operating a fish farm in case a disease breakout which has also help drive people to look for more solutions. Aquaculture producers urgently need therapeutic treatments, vaccines and specific skin care agents to control skin diseases in fish. Consequently, there has been evolution in the diagnostic techniques and therapies such as probiotics, antimicrobial and skin ailment vaccines.
Advancements in Disease Management for Fish Skin Diseases: Market Growth and Opportunities
-
The industry’s key drivers are diagnostic technologies in combination with vaccines and different antimicrobial and probiotic agents, all of which are currently rapidly developing and improving varieties for a fast and efficient identification and understanding in order to prevent and treat fish skin diseases. A general reason occurs from the discovery of other enhanced diagnostic methods that enable farmers to diagnose skin diseases in fish and affect the rapidness of the spread of infection. Furthermore, with the availability of vaccines and AMR particularly with skin diseases we are able to provide ultimate solutions so as to minimize on losses that is brought by diseases. There is also increasing focus on using of Probiotics where the strong point is supporting fish health, increase of the immune system and disease prevention.
- As the concern for safe food as well as sustainable sources of fish and other sea foods, the need for managing diseases in aqua farms is set to grow exponentially. Providers of aquaculture health products are then capitalizing on some of these technologies to develop more precise, socially conscious, and efficient solutions. As aquaculture shifts to increase production to feed the increasing global consumption of fish, great efforts are being made in preserving health of the stocks, as well as the minimizing of the effects of fish farming on the environment.
Fish Skin Disease Market Segment Analysis:
Fish Skin Disease Market is Segmented on the basis of into Type, Treatment type, Route of Administration, Distribution Channel, and Region
By Type, Ichthyosis vulgaris segment is expected to dominate the market during the forecast period
-
Ichthyosis vulgaris is the most common type of ichthyosis, which is easily characterized by scruffy and scaly skin. It begins in the early years of a child’s life and is typically an autosomal dominant disorder, where one of the parents will pass down the disease. The condition usually presents clinically in the forms of local thickening of the skin which is characterised by oedema, erythema and desquamation involving the limbs, abdominal wall and face. Many patients with HSIE maintain the diagnosis and symptoms into adulthood; however, common findings include patient self-report of increased quality of life with aging or experiencing decreases in the dryness and thickness of their skin.
- Ichthyosis vulgaris requires symptomatic treatment mainly addressing dryness and scaling of the skin, and enhancing skin texture and moisture. This is in particular made possible through the application of emollients that acts as softening agents for the skin. In more severe cases, tretinoin or any other topical retinoids may be prescribed to help facilitate cell turnover thereby minimising skin thickening.
By Distribution Channel, Hospital Pharmacies segment expected to held the largest share
-
Inpatient pharmacies are relied on heavily for dispensing and administration of ichthyosis medication especially for patients requiring severe and complicated treatment. These pharmacies are well placed to provide prescription drugs that are not usually found in retail pharmacies, including oral retinoids, corticosteroids and emollients. Inpatient pharmacies are also important in supplying compounded medications which are prepared specifically for the different needs of a specific patient in cases where mass-produced drugs from overthe- counter stores prove to be ineffective or unsuitable.
- Furthermore, hospital pharmacies are important in the long-term care of patients requiring systematic treatments that are administered orally and /or biologic agents like retinoids, commonly used with patients presenting with severe or resistant forms of ichthyosis. These medications should however be taken with a considerable amount of caution due to side effects, for instance liver toxicity or changes in lipid profiles. The given treatments are closely monitored by a hospital pharmacist who also supervises alterations in dosages of the medicine as well as informing the patients about proper ways of using such medications.
Fish Skin Disease Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
-
The major factors that create the demand for Fish Skin Disease Market in North America include the increasing need to practice Aquaculture as well as the growing demand for fish and seafood. With differences in dietary preferences, coupled with the increase in the population’s concern for their health, increase in the consumption of fish as a source of protein has created a boost fish farming. The increase in the need for fish has shifted focus toward sustainable production of fish as a result of the challenges posed by skin diseases including fin rot, fungus and bacterial attacks.
- The market’s growth is further backed with the rise of aquaculture and veterinary pharmaceutical company participants who are constantly devising various treatment to fish skin diseases. This involves dips, treated feeds, and vaccines, as well as topical treatments meant for skin infection in farmed fish. Furthermore, the encouragement by North American government bodies towards the fish health management programs has also stepped up. This has in turn emphasized the need for outbreak prevention and fish diseases management, thus creating a high market need for appropriate treatment.
Active Key Players in the Fish Skin Disease Market
- GSK Plc.,
- AbbVie Inc.
- Sonnet Biotherapeutics
- Krystal Biotech
- LEO Pharma
- Galderma
- Glenmark Pharmaceuticals Ltd.
- Mayne Pharma Group Limited
- Ortho Dermatologics
- Cellegy Pharmaceuticals
- Patagonia Pharmaceuticals,
- Crown Laboratories, Inc
- Other Active Players
|
Global Fish Skin Disease Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 1.40 Billion |
|
Forecast Period 2024-32 CAGR: |
9.80% |
Market Size in 2032: |
USD 3.25 Billion |
|
Segments Covered: |
By Type |
|
|
|
By Treatment type |
|
||
|
By Route of Administration |
|
||
|
By Distribution Channel |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the Report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Fish Skin Disease Market by Type
4.1 Fish Skin Disease Market Snapshot and Growth Engine
4.2 Fish Skin Disease Market Overview
4.3 Ichthyosis vulgaris
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Ichthyosis vulgaris: Geographic Segmentation Analysis
4.4 X-linked recessive ichthyosis
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 X-linked recessive ichthyosis: Geographic Segmentation Analysis
4.5 Others (Autosomal recessive congenital ichthyosis
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Others (Autosomal recessive congenital ichthyosis: Geographic Segmentation Analysis
4.6 etc.)
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 etc.): Geographic Segmentation Analysis
Chapter 5: Fish Skin Disease Market by Treatment type
5.1 Fish Skin Disease Market Snapshot and Growth Engine
5.2 Fish Skin Disease Market Overview
5.3 Corticosteroids
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Corticosteroids: Geographic Segmentation Analysis
5.4 Emollients
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Emollients: Geographic Segmentation Analysis
5.5 Retinoids
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Retinoids: Geographic Segmentation Analysis
5.6 Others (Keratolytics
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others (Keratolytics: Geographic Segmentation Analysis
5.7 etc.)
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 etc.): Geographic Segmentation Analysis
Chapter 6: Fish Skin Disease Market by Route of Administration
6.1 Fish Skin Disease Market Snapshot and Growth Engine
6.2 Fish Skin Disease Market Overview
6.3 Topical
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Topical: Geographic Segmentation Analysis
6.4 Oral
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Oral: Geographic Segmentation Analysis
6.5 Parenteral
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Parenteral: Geographic Segmentation Analysis
Chapter 7: Fish Skin Disease Market by Distribution Channel
7.1 Fish Skin Disease Market Snapshot and Growth Engine
7.2 Fish Skin Disease Market Overview
7.3 Hospital Pharmacies
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Hospital Pharmacies: Geographic Segmentation Analysis
7.4 Retail Pharmacies
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Retail Pharmacies: Geographic Segmentation Analysis
7.5 Online Pharmacies
7.5.1 Introduction and Market Overview
7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.5.3 Key Market Trends, Growth Factors and Opportunities
7.5.4 Online Pharmacies: Geographic Segmentation Analysis
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competitive Benchmarking
8.1.2 Fish Skin Disease Market Share by Manufacturer (2023)
8.1.3 Industry BCG Matrix
8.1.4 Heat Map Analysis
8.1.5 Mergers and Acquisitions
8.2 GSK PLC.
8.2.1 Company Overview
8.2.2 Key Executives
8.2.3 Company Snapshot
8.2.4 Role of the Company in the Market
8.2.5 Sustainability and Social Responsibility
8.2.6 Operating Business Segments
8.2.7 Product Portfolio
8.2.8 Business Performance
8.2.9 Key Strategic Moves and Recent Developments
8.2.10 SWOT Analysis
8.3 ABBVIE INC.
8.4 SONNET BIOTHERAPEUTICS
8.5 KRYSTAL BIOTECH
8.6 LEO PHARMA
8.7 GALDERMA
8.8 GLENMARK PHARMACEUTICALS LTD.
8.9 MAYNE PHARMA GROUP LIMITED
8.10 ORTHO DERMATOLOGICS
8.11 CELLEGY PHARMACEUTICALS
8.12 PATAGONIA PHARMACEUTICALS LLC
8.13 CROWN LABORATORIES INC
8.14 OTHER ACTIVE PLAYERS
Chapter 9: Global Fish Skin Disease Market By Region
9.1 Overview
9.2. North America Fish Skin Disease Market
9.2.1 Key Market Trends, Growth Factors and Opportunities
9.2.2 Top Key Companies
9.2.3 Historic and Forecasted Market Size by Segments
9.2.4 Historic and Forecasted Market Size By Type
9.2.4.1 Ichthyosis vulgaris
9.2.4.2 X-linked recessive ichthyosis
9.2.4.3 Others (Autosomal recessive congenital ichthyosis
9.2.4.4 etc.)
9.2.5 Historic and Forecasted Market Size By Treatment type
9.2.5.1 Corticosteroids
9.2.5.2 Emollients
9.2.5.3 Retinoids
9.2.5.4 Others (Keratolytics
9.2.5.5 etc.)
9.2.6 Historic and Forecasted Market Size By Route of Administration
9.2.6.1 Topical
9.2.6.2 Oral
9.2.6.3 Parenteral
9.2.7 Historic and Forecasted Market Size By Distribution Channel
9.2.7.1 Hospital Pharmacies
9.2.7.2 Retail Pharmacies
9.2.7.3 Online Pharmacies
9.2.8 Historic and Forecast Market Size by Country
9.2.8.1 US
9.2.8.2 Canada
9.2.8.3 Mexico
9.3. Eastern Europe Fish Skin Disease Market
9.3.1 Key Market Trends, Growth Factors and Opportunities
9.3.2 Top Key Companies
9.3.3 Historic and Forecasted Market Size by Segments
9.3.4 Historic and Forecasted Market Size By Type
9.3.4.1 Ichthyosis vulgaris
9.3.4.2 X-linked recessive ichthyosis
9.3.4.3 Others (Autosomal recessive congenital ichthyosis
9.3.4.4 etc.)
9.3.5 Historic and Forecasted Market Size By Treatment type
9.3.5.1 Corticosteroids
9.3.5.2 Emollients
9.3.5.3 Retinoids
9.3.5.4 Others (Keratolytics
9.3.5.5 etc.)
9.3.6 Historic and Forecasted Market Size By Route of Administration
9.3.6.1 Topical
9.3.6.2 Oral
9.3.6.3 Parenteral
9.3.7 Historic and Forecasted Market Size By Distribution Channel
9.3.7.1 Hospital Pharmacies
9.3.7.2 Retail Pharmacies
9.3.7.3 Online Pharmacies
9.3.8 Historic and Forecast Market Size by Country
9.3.8.1 Russia
9.3.8.2 Bulgaria
9.3.8.3 The Czech Republic
9.3.8.4 Hungary
9.3.8.5 Poland
9.3.8.6 Romania
9.3.8.7 Rest of Eastern Europe
9.4. Western Europe Fish Skin Disease Market
9.4.1 Key Market Trends, Growth Factors and Opportunities
9.4.2 Top Key Companies
9.4.3 Historic and Forecasted Market Size by Segments
9.4.4 Historic and Forecasted Market Size By Type
9.4.4.1 Ichthyosis vulgaris
9.4.4.2 X-linked recessive ichthyosis
9.4.4.3 Others (Autosomal recessive congenital ichthyosis
9.4.4.4 etc.)
9.4.5 Historic and Forecasted Market Size By Treatment type
9.4.5.1 Corticosteroids
9.4.5.2 Emollients
9.4.5.3 Retinoids
9.4.5.4 Others (Keratolytics
9.4.5.5 etc.)
9.4.6 Historic and Forecasted Market Size By Route of Administration
9.4.6.1 Topical
9.4.6.2 Oral
9.4.6.3 Parenteral
9.4.7 Historic and Forecasted Market Size By Distribution Channel
9.4.7.1 Hospital Pharmacies
9.4.7.2 Retail Pharmacies
9.4.7.3 Online Pharmacies
9.4.8 Historic and Forecast Market Size by Country
9.4.8.1 Germany
9.4.8.2 UK
9.4.8.3 France
9.4.8.4 The Netherlands
9.4.8.5 Italy
9.4.8.6 Spain
9.4.8.7 Rest of Western Europe
9.5. Asia Pacific Fish Skin Disease Market
9.5.1 Key Market Trends, Growth Factors and Opportunities
9.5.2 Top Key Companies
9.5.3 Historic and Forecasted Market Size by Segments
9.5.4 Historic and Forecasted Market Size By Type
9.5.4.1 Ichthyosis vulgaris
9.5.4.2 X-linked recessive ichthyosis
9.5.4.3 Others (Autosomal recessive congenital ichthyosis
9.5.4.4 etc.)
9.5.5 Historic and Forecasted Market Size By Treatment type
9.5.5.1 Corticosteroids
9.5.5.2 Emollients
9.5.5.3 Retinoids
9.5.5.4 Others (Keratolytics
9.5.5.5 etc.)
9.5.6 Historic and Forecasted Market Size By Route of Administration
9.5.6.1 Topical
9.5.6.2 Oral
9.5.6.3 Parenteral
9.5.7 Historic and Forecasted Market Size By Distribution Channel
9.5.7.1 Hospital Pharmacies
9.5.7.2 Retail Pharmacies
9.5.7.3 Online Pharmacies
9.5.8 Historic and Forecast Market Size by Country
9.5.8.1 China
9.5.8.2 India
9.5.8.3 Japan
9.5.8.4 South Korea
9.5.8.5 Malaysia
9.5.8.6 Thailand
9.5.8.7 Vietnam
9.5.8.8 The Philippines
9.5.8.9 Australia
9.5.8.10 New Zealand
9.5.8.11 Rest of APAC
9.6. Middle East & Africa Fish Skin Disease Market
9.6.1 Key Market Trends, Growth Factors and Opportunities
9.6.2 Top Key Companies
9.6.3 Historic and Forecasted Market Size by Segments
9.6.4 Historic and Forecasted Market Size By Type
9.6.4.1 Ichthyosis vulgaris
9.6.4.2 X-linked recessive ichthyosis
9.6.4.3 Others (Autosomal recessive congenital ichthyosis
9.6.4.4 etc.)
9.6.5 Historic and Forecasted Market Size By Treatment type
9.6.5.1 Corticosteroids
9.6.5.2 Emollients
9.6.5.3 Retinoids
9.6.5.4 Others (Keratolytics
9.6.5.5 etc.)
9.6.6 Historic and Forecasted Market Size By Route of Administration
9.6.6.1 Topical
9.6.6.2 Oral
9.6.6.3 Parenteral
9.6.7 Historic and Forecasted Market Size By Distribution Channel
9.6.7.1 Hospital Pharmacies
9.6.7.2 Retail Pharmacies
9.6.7.3 Online Pharmacies
9.6.8 Historic and Forecast Market Size by Country
9.6.8.1 Turkiye
9.6.8.2 Bahrain
9.6.8.3 Kuwait
9.6.8.4 Saudi Arabia
9.6.8.5 Qatar
9.6.8.6 UAE
9.6.8.7 Israel
9.6.8.8 South Africa
9.7. South America Fish Skin Disease Market
9.7.1 Key Market Trends, Growth Factors and Opportunities
9.7.2 Top Key Companies
9.7.3 Historic and Forecasted Market Size by Segments
9.7.4 Historic and Forecasted Market Size By Type
9.7.4.1 Ichthyosis vulgaris
9.7.4.2 X-linked recessive ichthyosis
9.7.4.3 Others (Autosomal recessive congenital ichthyosis
9.7.4.4 etc.)
9.7.5 Historic and Forecasted Market Size By Treatment type
9.7.5.1 Corticosteroids
9.7.5.2 Emollients
9.7.5.3 Retinoids
9.7.5.4 Others (Keratolytics
9.7.5.5 etc.)
9.7.6 Historic and Forecasted Market Size By Route of Administration
9.7.6.1 Topical
9.7.6.2 Oral
9.7.6.3 Parenteral
9.7.7 Historic and Forecasted Market Size By Distribution Channel
9.7.7.1 Hospital Pharmacies
9.7.7.2 Retail Pharmacies
9.7.7.3 Online Pharmacies
9.7.8 Historic and Forecast Market Size by Country
9.7.8.1 Brazil
9.7.8.2 Argentina
9.7.8.3 Rest of SA
Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies
Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
|
Global Fish Skin Disease Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 1.40 Billion |
|
Forecast Period 2024-32 CAGR: |
9.80% |
Market Size in 2032: |
USD 3.25 Billion |
|
Segments Covered: |
By Type |
|
|
|
By Treatment type |
|
||
|
By Route of Administration |
|
||
|
By Distribution Channel |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the Report: |
|
||
